この包括的なレポートは、現在のサプライヤーと潜在的な市場参入者が今後5年間にドイツの分子血液バンク市場における新たな機会を特定および評価するのに役立ち、業界幹部が効果的なビジネス、新製品開発、マーケティング戦略を開発できるように設計されています。
	このレポートは、ドイツにおける将来のマーケティングとテクノロジーのトレンドを調査しています。市場セグメント/検査場所ごとに検査量と売上予測を提供します。主要な自動分析装置と半自動分析装置の機能を比較します。有力な競合他社と新興の競合他社のプロフィールを作成します。そして、今後 5 年間にサプライヤーが直面する具体的な製品と市場の機会を特定します。
	PCR、PCR-RFLP、AS-PCR または PCR-SSP、マルチプレックス PCR、リアルタイム PCR、サンガー DNA シーケンス、パイロシーケンス
	BeadChip Array、BloodChip、Genome Lab SNP Stream、流体マイクロアレイ システム、TaqMan OpenArray、MALDI-TOF-MS、ミニシーケンス
	ABO、抗体パネル、抗体スクリーニング/間接抗グロブリン、抗原タイピング(C、c、Duffy、E、e、I、i、Kell、Kidd、Le a、b、MN、P、S、s)、抗グロブリン(直接、 C3 + IgG、IgG、C3)、クロスマッチング(即時スピン、完全クロスマッチ)、Rh(D、Du)
	エイズ(HIV NAT、HIV-1/2)、サイトメガロウイルス、肝炎(HAV NAT、HBV NAT、HBs抗原、抗HBc、HCV NAT、HCV、ALT/SGPT)、HTLV-I/II、パルボウイルスB19 NAT、梅毒、西ナイルウイルスNAT
						目次
						
	I. Introduction
	II. Worldwide Technology and Market Overview
	
	A. Major Blood Typing, Grouping and Infectious
	Disease Screening Tests
	 1. Blood Typing and Grouping Tests
	  a. ABO
	  b. Antibody Panels
	  c. Antibody Screening
	  d. Antigen Typing
	  e. Antiglobulin Test
	  f. Crossmatch
	  g. HLA Typing
	  h. Rh
	  i. Other Blood Groups
	 2. Blood Group Genotyping
	  a. PCR
	  b. PCR-RFLP
	  c. AS-PCR or PCR-SSP
	  d. Multiplex PCR
	  e. Real Time PCR
	  f. Sanger DNA Sequencing
	  g. Pyrosequencing
	  b. Microarrays
	   - BeadChip Array
	   - BloodChip
	   - Genome Lab SNP Stream
	   - Fluidic Microarray Systems
	   - TaqMan OpenArray
	   - MALDI-TOF-MS
	   - Mini-Sequencing
	 3. Infectious Disease Screening Tests
	  a. AIDS
	   - Structure and Composition
	   - Classification
	   - Origin of AIDS
	   - Animal Lentivirus Systems
	   - Virus Receptors
	   - HIV Infections in Humans
	    -Pathogenesis & Pathology
	    -Overview of Course of HIV Infection
	   - CD4T Lymphocytes and Memory Cells
	   - Monocytes and Macrophages
	   - Lymphoid Organs
	   - Neural Cells
	   - Viral Coinfections
	    -Clinical Findings
	   - Plasma Viral Load
	   - Pediactric AIDS
	    -Neurologic Disease
	    -Opportunistic Infections
	    -Protozoa
	    -Fungi
	    -Bacteria
	   - Viruses
	   - Cancer
	   - Immunity
	   - Laboratory Diagnosis
	    -Virus Isolation
	    -Serology
	    -Detection of Viral Nucleic Acid or Antigens
	   - Epidemiology
	    -Worldwide Spread of AIDS
	    -United States
	    -Routes of Transmission
	   - Prevention, Treatment, And Control
	    -Antiviral Drugs
	    -Vaccines Against HIV
	   - Transmission of HIV in Blood Products
	   - HIV Transmission in Transplant and Artificial Insemination Recipients
	   - Diagnostic Tests
	   - Enzyme Immunoassay Interpretation
	   - Specificity, Sensitivity, and Predictive
	Value of Enzyme Immunoassay
	   - Competition Assays
	   - Western Blot Technique
	   - Immuno-Fluorescence Assay (IFA)
	   - Radioimmunoprecipitation
	   - HIV-1/HIV-2 Combination Testing
	   - Methods of HIV-Antigen Detection
	   - Antigen Assays and Blood Screening
	   - Urine Tests
	   - DNA Probes
	   - Overview
	   - Quantitative Polymerase Chain Reaction
	   - In Situ PCR
	   - Needed Improvements
	   - Viral Load/Drug Resistance Testing
	   - Genotype and Phenotype Testing
	   - Blood Banking Considerations
	  b. Hepatitis
	   - Hepatitis A
	   - Hepatitis B
	    -Structure and Composition
	    -Replication of Hepatitis B Virus
	   - Hepatitis C
	   - Hepatitis D (Delta Hepatitis)
	   - Hepatitis E
	   - Hepatitis G
	   - Hepatitis Virus Infections In Humans
	    -Pathology
	   - Clinical Findings
	   - Laboratory Features
	    -Hepatitis A
	    -Hepatitis B
	    -Hepatitis C
	    -Hepatitis D
	    -Hepatitis E
	   - Virus-Host Immune Reactions
	   - Epidemiology
	    -Hepatitis A
	    -Hepatitis B
	    -Hepatitis C
	    -Hepatitis D (Delta Agent)
	   - Vaccines and Drugs
	  c. Cytomegalovirus
	   - Background
	   - Chorioretinitis
	   - Gastrointestinal
	   - Central Nervous System Disease
	   - Diagnostic Tests
	   - Vaccines and Drugs
	  d. Syphilis
	   - Background
	   - Diagnostic Tests
	   - Vaccines and Drugs
	  e. West Nile Virus
	   - Background
	   - Clinical Syndromes
	   - Diagnostic Tests
	   - Vaccines and Drugs
	  f. Parvovirus B19
	   - Microbiology
	   - Epidemiology
	   - Clinical Syndromes
	    -Erythema Infectiosum Slapped (cheek)
	    -Adult Polyarthropathy
	    -Transient Aplastic Crisis
	    -Transient Pancytopenia
	    -Red Cell Aplasia in the Immunocompromised
	    -Perinatal Infections
	   - Diagnosis
	   - Treatment
	  g. Creutzfeldt-Jakob’s Disease
	   - Background
	   - Transmission
	   - Diagnostic Tests
	   - Major Commercial and Academic Players
	    -Bayer
	    -Disease Sciences/BioTec Global
	    -Imperial College School of Medicine
	    -Ortho-Clinical Diagnostics
	    -Pall
	    -ProMetic Life Sciences
	    -Proteome Sciences/Idexx
	    -Q-One Biotech
	    -Serono
	    -U.S. Agricultural Research Service
	   - Drugs
	   - Vaccines
	  h. Malaria
	  i. Chagas Disease
	  j. Babesiosis
	 4. Pathogen Reduction
	 5. Leukocyte Reduction
	   - Background
	   - Methods
	B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
	   - Abbott
	   - Beckman Coulter/Danaher
	   - Becton Dickinson
	   - Bio-Rad
	   - BioMerieux
	   - Cepheid
	   - Curtis Unyvero
	   - Gen-Probe/Hologic
	   - GenMark
	   - Grifols
	   - HTG
	   - Immucor
	   - Life Technologies
	   - Nanosphere
	   - Ortho-Clinical Diagnostics
	   - Qiagen
	   - Roche
	   - Sarstedt
	   - Siemens
	   - Tecan
	C. Major in Vitro Diagnostic Technologies and Their Potential Applications
	 1. Molecular Diagnostics
	  a. Overview
	  b. NAT
	 2. Monoclonal and Polyclonal Antibodies
	 3. Immunoassays
	  a. Technological Principle
	  b. Chemiluminescence
	  c. Enzyme Immunoassays (EIA)
	   - Overview
	   - ELISA
	   - EMIT
	   - Electrochemical
	  d. Radioimmunoassays (RIA)
	  e. Immunoprecipitation
	  f. Affinity Chromatography
	 4. Microtitration Plates
	 5. IT and Automation
	 6. Lasers
	 7. Robotics
	 8. Synthetic Red Cell Substitutes
	 9. Genetically Engineered Blood Components
	  a. Albumin
	  b. Factor VIII
	  c. Alpha-2 Antiplasmin
	  d. Antithrombin III
	  e. Factor IX
	  f. Von Willebrand's Factor
	  g. Fibrinogen
	  h. t-PA
	 10. Blood Preservation
	 11. Autologous Blood Transfusion/Freezing
	III. Germany
	
	A. Executive Summary
	B. Business Environment
	C. Market Structure
	D. Market Size, Growth and Major Supplier
	Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
	IV. Major Product Development Opportunities
	
	A. Molecular Blood Typing and Grouping
	B. Infectious Disease Screening
	C. Auxiliary
	V. Alternative Market Penetration Strategies
	
	A. Internal Development
	B. Collaborative Arrangements
	C. University Contracts
	VI. Potential Market Entry Barriers and Risks
	
	A. Market Maturity
	B. Cost Containment
	C. Competition
	D. Technological Edge and Limitations
	E. Patent Protection
	VII. Competitive Assessments
	
	Abbott
	Beckman Coulter/Danaher
	Becton Dickinson
	Biokit
	bioMerieux
	Bio-Rad
	Diagast
	DiaSorin
	Fujirebio
	Grifols
	Hologic
	LabCorp
	Proteome Sciences
	Quest Diagnostics
	QuidelOrtho
	Roche
	Siemens Healthineers
	Tecan
	Thermo Fisher
	Werfen/Immucor
	List of Tables
	
	Major Companies Developing or Marketing
	Blood Typing and Grouping Tests
	Major Companies Developing or Marketing
	HLA Typing Tests
	Major Companies Developing or Marketing
	AIDS Tests
	Major Companies Developing or Marketing
	Hepatitis Tests
	Major Companies Developing or Marketing
	CMV Tests
	Major Companies Developing or Marketing
	Syphilis Tests
	Major Companies Developing or Marketing
	Blood Bank Analyzers
	Executive Summary Table: Germany, Total Blood Bank
	Test Volume and Reagent Sales Forecast by Test Category
	Germany, Facilities Performing Blood
	Bank Tests by Market Segment
	Germany, Hospital Laboratories Performing
	Blood Bank Tests by Bed Size
	Germany, Commercial/Private Laboratories
	Performing Blood Bank Tests by Annual Test Volume
	Germany, All Market Segments Blood Typing and Grouping Test Volume Forecast by Market
	Segment
	Germany, All Market Segments Blood Typing and Grouping Test Volume Forecast
	Germany, Hospital Laboratories Blood
	Typing and Grouping Test Volume Forecast
	Germany, Blood Banks Blood Typing and Grouping Test Volume Forecast
	Germany, Commercial/Private Laboratories
	Blood Typing and Grouping Test Volume Forecast
	Germany, All Market Segments Infectious
	Disease Screening Test Volume Forecast by Market Segment
	Germany, All Market Segments Infectious
	Disease Screening Test Volume Forecast
	Germany, Blood Banks Infectious Disease
	Screening Test Volume Forecast
	Germany, Commercial/Private Laboratories
	Infectious Disease Screening Test Volume Forecast
	Germany, Hospital Laboratories Infectious
	Disease Screening Test Volume Forecast
	Germany, All Market Segments Blood Typing and Grouping Reagent Market Forecast by Market Segment
	Germany, All Market Segments Blood Typing and Grouping Reagent Market Forecast by Major Test
	Germany, Hospital Laboratories Blood
	Typing and Grouping Reagent Market Forecast by Major Test
	Germany, Blood Banks Blood Typing and Grouping Reagent Market By Major Test Forecast
	Germany, Commercial/Private Laboratories
	Blood Typing and Grouping Reagent Market Forecast by Major Test
	Germany, All Market Segments Infectious
	Disease Screening Reagent Market Forecast by Market Segment
	Germany, All Market Segments Infectious
	Disease Screening Reagent Market Forecast by Test
	Germany, Blood Banks Infectious Disease
	Screening Reagent Market Forecast by Test
	Germany, Commercial/Private Laboratories
	Infectious Disease Screening Reagent Market Forecast by Test
	Germany, Hospital Laboratories Infectious
	Disease Screening Reagent Market Forecast by Test
	Germany, Major Suppliers of Blood Typing and Grouping Reagents Estimated Sales and Market Shares
	Germany, HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier
	Germany, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier
	Germany, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier
	Germany, CMV Blood Screening Market, Reagent Sales by Major Supplier